Amplifon S.p.A. (GB:0N61)
LSE:0N61
0N61 Stock Chart & Stats
€9.15
-€0.64(-2.45%)
At close: 4:00 PM EST
€9.15
-€0.64(-2.45%)
Day’s Range― - ―
52-Week Range€7.84 - €21.47
Previous CloseN/A
Volume73.02K
Average Volume (3M)88.45K
Market Cap
€2.05B
Enterprise Value€3.23B
Total Cash (Recent Filing)€308.88M
Total Debt (Recent Filing)€1.53B
Price to Earnings (P/E)34.1
Beta1.35
Next Earnings
May 05, 2026EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.23
Shares Outstanding226,388,630
10 Day Avg. Volume39,207
30 Day Avg. Volume88,446
Financial Highlights & Ratios
PEG Ratio-0.91
Price to Book (P/B)3.12
Price to Sales (P/S)1.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€9.07Price Target Upside-0.87% Downside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)0.78
Revenue Forecast (FY)€2.45B
Bulls Say, Bears Say
Bulls Say
Clinic Network & Recurring ServicesAmplifon’s core model bundles device sales with hearing tests, fittings and after-sales care across a large multi-country clinic network. That creates recurring service revenues, high customer retention and steady patient flow, supporting durable demand and repeat cash generation.
Stable EBITDA Margin BaseDespite recent pressure, historically strong EBITDA margins indicate underlying operational leverage from standardized clinical processes and purchasing scale. A healthy EBITDA base supports ability to fund operations and reinvest in the network once top-line stabilizes.
Prior Positive Free Cash Flow And Asset BaseMulti-year positive free cash flow through 2024 and a sizeable asset base with positive equity provide financial ballast. This historical cash generation record implies the company can recover cash conversion if revenue and margins normalize, helping fund maintenance capex and services.
Bears Say
Elevated LeverageSustained leverage at ~1.4–1.5x reduces financial flexibility and raises refinancing and interest-rate vulnerability. With profitability weakening, the debt load limits ability to pursue M&A, absorb shocks, or increase investment without raising capital or cutting distributions.
Margin CompressionA sharp multi-year decline in net margin signals structural pressure on pricing, costs, or product mix. Lower margins erode internal cash generation and returns on equity, making it harder to sustain reinvestment, dividends or debt service if margins do not recover.
Deteriorating Cash ConversionAn abrupt fall to zero free cash flow removes a key buffer for capital spending, debt reduction and payouts. Persistent cash conversion weakness increases reliance on external financing and constrains strategic choices until working capital or profitability issues are addressed.
Amplifon S.p.A. News
0N61 FAQ
What was Amplifon S.p.A.’s price range in the past 12 months?
Amplifon S.p.A. lowest share price was €7.84 and its highest was €21.47 in the past 12 months.
What is Amplifon S.p.A.’s market cap?
Amplifon S.p.A.’s market cap is €2.05B.
When is Amplifon S.p.A.’s upcoming earnings report date?
Amplifon S.p.A.’s upcoming earnings report date is May 05, 2026 which is in 31 days.
How were Amplifon S.p.A.’s earnings last quarter?
Amplifon S.p.A. released its earnings results on Mar 04, 2026. The company reported €0.23 earnings per share for the quarter, beating the consensus estimate of €0.228 by €0.002.
Is Amplifon S.p.A. overvalued?
According to Wall Street analysts Amplifon S.p.A.’s price is currently Overvalued.
Does Amplifon S.p.A. pay dividends?
Amplifon S.p.A. does not currently pay dividends.
What is Amplifon S.p.A.’s EPS estimate?
Amplifon S.p.A.’s EPS estimate is 0.13.
How many shares outstanding does Amplifon S.p.A. have?
Amplifon S.p.A. has 226,388,630 shares outstanding.
What happened to Amplifon S.p.A.’s price movement after its last earnings report?
Amplifon S.p.A. reported an EPS of €0.23 in its last earnings report, beating expectations of €0.228. Following the earnings report the stock price went down -2.179%.
Which hedge fund is a major shareholder of Amplifon S.p.A.?
Currently, no hedge funds are holding shares in GB:0N61
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Amplifon S.p.A.
Amplifon S.p.A. retails hearing care products and services that help people rediscover various emotions of sound. The company offers ampli-easy, ampli-mini, ampli-connect, and ampli-energy hearing devices. It also provides fitting of customized products. As of March 18, 2022, the company operated a network of approximately 9,200 points of sale in 25 countries and 5 continents. The company also sells its products through 1,350 franchisees. It has operations in Europe, the Middle East, Africa, the United States, Asia, and Oceania. The company was founded in 1950 and is headquartered in Milan, Italy.
0N61 Stock 12 Month Forecast
Average Price Target
€9.07
▼(-0.87% Downside)
Technical Analysis
Options Prices
Currently, No data available
---